139 related articles for article (PubMed ID: 7630631)
1. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.
Hennig G; Behrens J; Truss M; Frisch S; Reichmann E; Birchmeier W
Oncogene; 1995 Aug; 11(3):475-84. PubMed ID: 7630631
[TBL] [Abstract][Full Text] [Related]
2. Regulation of E-cadherin gene expression during tumor progression: the role of a new Ets-binding site and the E-pal element.
Rodrigo I; Cato AC; Cano A
Exp Cell Res; 1999 May; 248(2):358-71. PubMed ID: 10222128
[TBL] [Abstract][Full Text] [Related]
3. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
Kao RH; Huang LC; Hsu YH
Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
5. P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancer.
Jarrard DF; Paul R; van Bokhoven A; Nguyen SH; Bova GS; Wheelock MJ; Johnson KR; Schalken J; Bussemakers M; Isaacs WB
Clin Cancer Res; 1997 Nov; 3(11):2121-8. PubMed ID: 9815605
[TBL] [Abstract][Full Text] [Related]
6. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation regulates cadherin switching in squamous cell carcinoma.
Chen Q; Lipkina G; Song Q; Kramer RH
Biochem Biophys Res Commun; 2004 Mar; 315(4):850-6. PubMed ID: 14985090
[TBL] [Abstract][Full Text] [Related]
8. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
9. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF
Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090
[TBL] [Abstract][Full Text] [Related]
10. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
[TBL] [Abstract][Full Text] [Related]
11. Induction of transcripts derived from promoter III of the acetyl-CoA carboxylase-alpha gene in mammary gland is associated with recruitment of SREBP-1 to a region of the proximal promoter defined by a DNase I hypersensitive site.
Barber MC; Vallance AJ; Kennedy HT; Travers MT
Biochem J; 2003 Oct; 375(Pt 2):489-501. PubMed ID: 12871210
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
[TBL] [Abstract][Full Text] [Related]
13. Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts.
Le Mée S; Fromigué O; Marie PJ
Exp Cell Res; 2005 Jan; 302(1):129-42. PubMed ID: 15541732
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Graff JR; Herman JG; Lapidus RG; Chopra H; Xu R; Jarrard DF; Isaacs WB; Pitha PM; Davidson NE; Baylin SB
Cancer Res; 1995 Nov; 55(22):5195-9. PubMed ID: 7585573
[TBL] [Abstract][Full Text] [Related]
15. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements.
Hajra KM; Ji X; Fearon ER
Oncogene; 1999 Dec; 18(51):7274-9. PubMed ID: 10602481
[TBL] [Abstract][Full Text] [Related]
16. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance.
Chang HW; Chow V; Lam KY; Wei WI; Yuen A
Cancer; 2002 Jan; 94(2):386-92. PubMed ID: 11900224
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
18. TATA box-binding protein-associated factor 12 is important for RAS-induced transformation properties of colorectal cancer cells.
Voulgari A; Voskou S; Tora L; Davidson I; Sasazuki T; Shirasawa S; Pintzas A
Mol Cancer Res; 2008 Jun; 6(6):1071-83. PubMed ID: 18567809
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation in promoter region of E-cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma.
Saito T; Nishimura M; Yamasaki H; Kudo R
Cancer; 2003 Feb; 97(4):1002-9. PubMed ID: 12569599
[TBL] [Abstract][Full Text] [Related]
20. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
Mauro L; Catalano S; Bossi G; Pellegrino M; Barone I; Morales S; Giordano C; Bartella V; Casaburi I; Andò S
Cancer Res; 2007 Apr; 67(7):3412-21. PubMed ID: 17409452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]